ES2060957T3 - Antibiotico antitumoral bu-3285t. - Google Patents

Antibiotico antitumoral bu-3285t.

Info

Publication number
ES2060957T3
ES2060957T3 ES90307579T ES90307579T ES2060957T3 ES 2060957 T3 ES2060957 T3 ES 2060957T3 ES 90307579 T ES90307579 T ES 90307579T ES 90307579 T ES90307579 T ES 90307579T ES 2060957 T3 ES2060957 T3 ES 2060957T3
Authority
ES
Spain
Prior art keywords
antibiotic
antitumor
relates
compound
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90307579T
Other languages
English (en)
Inventor
Hiroaki Ohkuma
Koji Tomita
Masataka Konishi
Hideo Kamei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2060957T3 publication Critical patent/ES2060957T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL COMPUESTO ANTIBIOTICO ANTITUMORAL BU-3285T Y A SU PREPARACION. EL COMPUESTO SE OBTIENE MEDIANTE EL CULTIVO DE UNA NUEVA CEPA DE "CHAINIA ROSEA", PRESENTANDO UNA ACTIVIDAD ANTITUMORAL Y ANTIFUNGICA. ASIMISMO, SE REFIERE AL DERIVADO DESULFATADO DE BU-3285T QUE SE OBTIENE MEDIANTE EL TRATAMIENTO DE BU-3285T CON UNA ENZIMA SULFATASA. EL DESULFATO BU-3285T POSEE ACTIVIDAD ANTITUMORAL.
ES90307579T 1989-07-12 1990-07-11 Antibiotico antitumoral bu-3285t. Expired - Lifetime ES2060957T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37867789A 1989-07-12 1989-07-12
US07/431,423 US4952709A (en) 1989-07-12 1989-11-03 Antitumor antibiotic BU-3285T compounds

Publications (1)

Publication Number Publication Date
ES2060957T3 true ES2060957T3 (es) 1994-12-01

Family

ID=27008309

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90307579T Expired - Lifetime ES2060957T3 (es) 1989-07-12 1990-07-11 Antibiotico antitumoral bu-3285t.

Country Status (13)

Country Link
US (1) US4952709A (es)
EP (1) EP0408336B1 (es)
JP (1) JPH0684366B2 (es)
KR (1) KR930005868B1 (es)
AT (1) ATE111091T1 (es)
AU (1) AU617950B2 (es)
CA (1) CA2020878C (es)
DE (1) DE69012245T2 (es)
DK (1) DK0408336T3 (es)
ES (1) ES2060957T3 (es)
FI (1) FI95286C (es)
IE (1) IE64853B1 (es)
PT (1) PT94670B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100786785B1 (ko) * 2006-11-27 2007-12-18 한국생산기술연구원 저공해 예혼합 연소기

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578383A (en) * 1982-12-07 1986-03-25 Warner-Lambert Company CL 1565 antibiotic compounds
EP0128651A3 (en) * 1983-05-12 1987-01-07 Warner-Lambert Company Pyranones and related compounds and methods for their production and use
US4680416A (en) * 1983-05-12 1987-07-14 Warner-Lambert Company Antibiotic CL-1565 complex derivatives
US4495286A (en) * 1983-05-25 1985-01-22 Warner-Lambert Company Antibiotic complex producing bacterial culture
CA1232852A (en) * 1983-09-12 1988-02-16 Gerard C. Hokanson Cl-1957b antibiotic compound and its production
US4792522A (en) * 1983-12-12 1988-12-20 Bristol-Myers Company Rigolettone antitumor complex

Also Published As

Publication number Publication date
AU5892890A (en) 1991-01-17
AU617950B2 (en) 1991-12-05
CA2020878A1 (en) 1991-01-13
IE64853B1 (en) 1995-09-06
EP0408336A3 (en) 1991-04-03
EP0408336B1 (en) 1994-09-07
IE902535A1 (en) 1991-02-13
KR920002791A (ko) 1992-02-28
KR930005868B1 (ko) 1993-06-25
PT94670B (pt) 1997-07-31
FI903459A0 (fi) 1990-07-09
PT94670A (pt) 1991-03-20
CA2020878C (en) 1996-06-18
DE69012245D1 (de) 1994-10-13
FI95286C (fi) 1996-01-10
ATE111091T1 (de) 1994-09-15
DK0408336T3 (da) 1994-10-10
FI95286B (fi) 1995-09-29
JPH0684366B2 (ja) 1994-10-26
US4952709A (en) 1990-08-28
JPH03115276A (ja) 1991-05-16
EP0408336A2 (en) 1991-01-16
DE69012245T2 (de) 1995-01-05

Similar Documents

Publication Publication Date Title
DK94088D0 (da) Stabiliserede praeparater
MY100849A (en) Enhancement of biocide.
DK0537622T3 (da) Et antifungalt middel, dets fremstilling og mikroorganismer dertil
ES2132279T3 (es) Analogo de prostaglandina.
IT1156487B (it) Procedimento e microrganismi per la produzione della l lisina mediante fermentazione
ATE86960T1 (de) Cyclopropanderivate.
ES2060957T3 (es) Antibiotico antitumoral bu-3285t.
DE3885394D1 (de) Teicoplaninähnliche Derivate.
DK508885A (da) Esterderivat af antibiotekum l 17046 og fremgangsmaade til fremstilling deraf
DE68918562D1 (de) Menschliche myeloperoxidase und therapeutische verwendung.
GR3007079T3 (es)
AT388566B (de) Neues antibiotikum a 42867 und dessen additionssalze
ATE114153T1 (de) 3,6-diamino-2,5-pyrazindicarbonitril und ihre herstellung.
DE68901024D1 (de) Gegen anaerobe bakterien wirksame antibiotika, ihre produktion und enterobakter-staemme, die sie produzieren.
FI873489A0 (fi) Foerfarande foer framstaellning av 4-androsten-3,17-dion och 1,4-androstadien-3,17-dion.
SU1455633A1 (ru) О,о-диизопропил-о-[1, 1-диметил-2-пропилтио-2-(о-о-диизопропилфосфорил)- имино]-этилфосфат, обладающий бактерицидной активностью
SU1660376A1 (ru) N-диэтокситиофосфорил-1-метилмеркаптометилидентетрагидроизохинолин, обладающий акарицидной активностью
NO872824L (no) Mellomprodukter for fremstilling av cefalosporiner.
ITMI930218A0 (it) Derivato peptico della rimantadina ad attivita' immunomodulante
DE3879440D1 (de) Dactylocyclin a und dactylocyclin b.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 408336

Country of ref document: ES